Czech National Bank Has $11.87 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Czech National Bank lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,543 shares of the company's stock after purchasing an additional 1,691 shares during the period. Czech National Bank's holdings in HCA Healthcare were worth $11,869,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Private Wealth LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $49,000. American Century Companies Inc. boosted its stake in shares of HCA Healthcare by 60.0% during the 2nd quarter. American Century Companies Inc. now owns 23,024 shares of the company's stock valued at $7,397,000 after buying an additional 8,633 shares during the period. Rathbones Group PLC increased its stake in shares of HCA Healthcare by 1.9% in the second quarter. Rathbones Group PLC now owns 48,255 shares of the company's stock worth $15,503,000 after acquiring an additional 879 shares during the last quarter. Brown Brothers Harriman & Co. grew its stake in HCA Healthcare by 279.3% in the second quarter. Brown Brothers Harriman & Co. now owns 2,902 shares of the company's stock valued at $932,000 after purchasing an additional 2,137 shares in the last quarter. Finally, Fairfield Financial Advisors LTD acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $500,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

HCA Healthcare Price Performance

HCA Healthcare stock traded down $2.55 during mid-day trading on Tuesday, hitting $305.63. 1,048,867 shares of the company were exchanged, compared to its average volume of 1,509,207. The business has a fifty day moving average of $320.56 and a 200 day moving average of $353.55. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1-year low of $276.50 and a 1-year high of $417.14. The company has a market capitalization of $77.42 billion, a PE ratio of 13.72, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.86%. The ex-dividend date was Friday, December 13th. HCA Healthcare's payout ratio is currently 11.85%.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent research reports. Truist Financial cut their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Barclays reduced their target price on HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating for the company in a report on Friday, November 8th. Wells Fargo & Company cut shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and reduced their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.